Add to ORKGSunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironmen
Based on preclinical data available in the RIP1-Tag2 transgenic mouse model, sunitinib is an inhibit...
Sunitinib is an oral small-molecule multitargeted receptor tyrosine kinase inhibitor that has recent...
Sunitinib is a multikinase inhibitor approved for use in some human solid malignancies, including r...
Malignant gliomas can be counted to the most devastating tumors in humans. Novel therapies do not ac...
Neuroblastoma, a tumor of the peripheral sympathetic nervous system, is the most common and deadly e...
<div><p>Neuroblastoma, a tumor of the peripheral sympathetic nervous system, is the most common and ...
BACKGROUND: Sunitinib is an inhibitor of the multiple receptor tyrosine kinases (RTKs) for cancer t...
Medulloblastomas are the most frequent malignant brain iangio liferat stom ase an totic Cip1 ducer i...
Pancreatic neuroendocrine tumors (PNETs) are becoming increasingly common, with the majority of pati...
Neuroblastoma (NB) is one of the most common pediatric solid tumors originating from the neural cres...
Preclinical studies have suggested that sunitinib accelerates metastases in animals, ascribing this ...
The multitargeted tyrosine kinase inhibitor sunitinib has shown activity against pancreatic neuroend...
SummaryPreclinical studies have suggested that sunitinib accelerates metastases in animals, ascribin...
AbstractNeuroblastoma (NB) is one of the most common pediatric solid tumors originating from the neu...
<p>(<b>A</b>) SH-SY5Y, SK-N-BE and SK-N-AS neuroblastoma cells were treated with increasing concentr...
Based on preclinical data available in the RIP1-Tag2 transgenic mouse model, sunitinib is an inhibit...
Sunitinib is an oral small-molecule multitargeted receptor tyrosine kinase inhibitor that has recent...
Sunitinib is a multikinase inhibitor approved for use in some human solid malignancies, including r...
Malignant gliomas can be counted to the most devastating tumors in humans. Novel therapies do not ac...
Neuroblastoma, a tumor of the peripheral sympathetic nervous system, is the most common and deadly e...
<div><p>Neuroblastoma, a tumor of the peripheral sympathetic nervous system, is the most common and ...
BACKGROUND: Sunitinib is an inhibitor of the multiple receptor tyrosine kinases (RTKs) for cancer t...
Medulloblastomas are the most frequent malignant brain iangio liferat stom ase an totic Cip1 ducer i...
Pancreatic neuroendocrine tumors (PNETs) are becoming increasingly common, with the majority of pati...
Neuroblastoma (NB) is one of the most common pediatric solid tumors originating from the neural cres...
Preclinical studies have suggested that sunitinib accelerates metastases in animals, ascribing this ...
The multitargeted tyrosine kinase inhibitor sunitinib has shown activity against pancreatic neuroend...
SummaryPreclinical studies have suggested that sunitinib accelerates metastases in animals, ascribin...
AbstractNeuroblastoma (NB) is one of the most common pediatric solid tumors originating from the neu...
<p>(<b>A</b>) SH-SY5Y, SK-N-BE and SK-N-AS neuroblastoma cells were treated with increasing concentr...
Based on preclinical data available in the RIP1-Tag2 transgenic mouse model, sunitinib is an inhibit...
Sunitinib is an oral small-molecule multitargeted receptor tyrosine kinase inhibitor that has recent...
Sunitinib is a multikinase inhibitor approved for use in some human solid malignancies, including r...